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A B S T R A C T
Although chitosan nanoparticles (CNs) became a promising tool for several biological and medical
applications owing to their inherent biocompatibility and biodegradability features, studies regarding
their effects on cytotoxic and cytostatic properties still remain insufficient. Therefore, in the present
study, we decided to perform comprehensive analysis of the interactions between CNs–pKindling-Red-
Mito (pDNA) and different cell line models derived from blood system and human solid tissues cancers.
The resulting CNs-pDNA was investigated in terms of their cellular uptake, transfection efficiency, and
physico-chemical, cytotoxic and cytostatic properties. The nanoparticles showed high encapsulation
efficiency and physical stability for various formulations even after two days time period. Moreover, high
gene expression levels were observed after 96 h of transfection. CNs-pDNA treatment, despite the
absence of oxidative stress induction, caused cell cycle arrest in G0/G1 phase and as a consequence led to
premature senescence which turned out to be both p21-dependent and p21-independent. Also, observed
DNMT2 upregulation may suggest the activation of different pathways protecting from the results of CNs-
mediated stress. In conclusion, treatment of different cell lines with CNs-pDNA showed that their
biocompatibility was limited and the effects were cell type-dependent.
ã 2016 Elsevier B.V. All rights reserved.
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Gene therapy is one of the most promising strategies for
treatment of various diseases such as cancer and inflammatory,
neurological, cardiovascular or metabolic disorders (Ibraheem
et al., 2014; Ragelle et al., 2014). Simultaneously, the choice of a
good transfection agent for delivery of nucleic acids is critical for
each gene transfer procedure, however most commercially
available transfection agents have still some limitations (Perez-
Martinez et al., 2011). Recently, in gene delivery, viral vectors have
been used due to the high transfection efficiency compared to non-
viral gene delivery systems. However, toxicity issues such as
immunogenicity and mutagenicity limit the clinical applications of* Corresponding author at: Izmir Institute of Technology, Science Faculty,
Department of Chemistry Urla, Izmir, Turkey.
E-mail addresses: gulsahsanli@iyte.edu.tr, gulsahsanli@hotmail.com
(G. Şanlı-Mohamed).
1 These authors contributed equally to this work.
http://dx.doi.org/10.1016/j.ijpharm.2016.09.058
0378-5173/ã 2016 Elsevier B.V. All rights reserved.the viral vectors. Taking into account safety considerations, non-
viral vectors are thought to be more promising nucleic acid carriers
compared to viral vectors (Ishii et al., 2001).
Among various non-viral vectors, chitosan (CS) is one of the
most commonly studied polymer since its positive charges under
slightly acidic conditions allow its interaction with nucleic acids
and thus formation of complexes of nanoparticles (Ragelle et al.,
2014). On the other side, it is known that many biological effects
caused by nanoparticles depend on their size, shape, used dose,
behavior of nanoparticles in enviroment (i.e., whether or not their
aggregation occurs) and cell type (i.e., suspended versus adherent
cell types or healthy versus cancer cell types) (Fu et al., 2014;
Mytych et al., 2015a, 2015b). It has been shown that plasmid DNA
loaded chitosan nanoparticles (CNs-pDNA) did not cause any
cytotoxicity to macrophages (which differentiate from monocytes)
(Chellat et al., 2005). Despite these promising results, potential
side effects including cytostatic or cytotoxic effects caused by
biodegradable nanomaterials like CNs or/and type of used
expression vector system on different cell types are poorly
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transduction might affect the cytophysiology of the targeted cell.
For example, it is widely accepted that tagged chromosome
proteins may affect the motion of chromosomes. In general, green
fluorescent protein (GFP) is considered nontoxic both in in vitro
and in vivo systems. However, there are some reports showing side
effects of GFP in in vitro and in vivo studies, but the details of
molecular mechanism of these interactions still remain unclear
(Agbulut et al., 2006, 2007; Baens et al., 2006; Huang et al., 2000;
Liu et al., 1999). Recently, it has been shown that Ku80 attenuates
cytotoxicity induced by green fluorescent protein transduction
independently of non-homologous end joining (Koike et al., 2013).
Moreover, the application of biodegradable nanomaterials as
nucleic acid delivery systems for living organisms including
humans raises also other important questions about the impact
of CNs on efficiency of pDNA condensation. Matsumoto et al.
(2009) showed the differences in the transcriptional activity of
pDNAs transfected into cells using either cationic lipids or cationic
polymers (Matsumoto et al., 2009).
Therefore, in this study, we aimed to use the ionic gelation
method for the encapsulation of pKindling-Red-Mito vector into
chitosan nanoparticles and to evaluate their potential as safe-
nanocarriers on different cell line models derived from human
solid tissues cancers (HeLa and MDA-MB-231) and monocytes
(derived from peripheral blood cancer—THP-1).
2. Materials and methods
2.1. Materials
Plasmid DNA (pKindling-Red-Mito) encoding red fluorescent
protein (KFP) and neomycin resistance gene were purchased from
Evrogen JSC, Russia. All other reagents, if not otherwise mentioned,
were purchased from Sigma Aldrich, Poland and were of analytical
grade.
2.2. Preparation and characterization of CNs-pDNA
CNs-pDNA were synthesized following the Calvo’s ionic
gelation procedure (Calvo et al., 1997) with some modifications.
According to this procedure, low molecular weight chitosan (50–
190 kDa and the degree of acetylation of 75–85%) was used with
tripolyphosphate (TPP) as a crosslinker. Chitosan stock solution
(0.4%) was prepared by dissolving the chitosan powder in 1% (v/v)
acetic acid under magnetic stirring. The solution was filtered
through sterile 0.45 mm membrane and the pH was adjusted to 5.5.
Nanoparticles were spontaneously obtained upon addition of TPP
(0.1%) and pDNA in nuclease free water to chitosan solution
(chitosan to TPP weight ratio of 4:1). CNs-pDNA at weight ratios of
500:1, 300:1 and 100:1 were generated at room temperature by
adding a constant pDNA concentration of 10 mg/ml. After complex
formation, CNs-pDNA solution was centrifuged at 13500 rpm for
30 min and then the pellet was dissolved in 2 mL of nuclease free
water (pH 7.4) for further use in the in vitro studies.
CNs-pDNA were characterized using dynamic light scattering
(DLS) on a Zetasizer Nano ZS (Malvern Instruments Ltd, UK) for
determination of mean particle diameter (Z-Average), polydis-
persion index (P.I.) and zeta potential values. Each measurement
was performed in triplicate at a temperature of 25 C with an angle
of 173 in ultrapure water.
For the morphological characterization of particles, atomic
force microscopy (AFM) was used. All the AFM samples have been
deposited on freshly cleaved muscovite mica, incubated for 10 min,
and then rinsed with ultrapure water, gently flushed with a stream
of nitrogen for drying. The Height Sensor and Peak Force Error AFM
images were analyzed with Nanoscope Analysis software (v. 1.40Bruker Corporation, Germany). Mean diameter and zeta potential
of the nanoparticles were estimated by the software provided by
Malvern Instruments Ltd.
2.3. Evaluation of encapsulation efficiency
To determine the amount of plasmid DNA encapsulated in the
chitosan nanoparticles, the difference between the total amount of
pDNA and the amount of non-entrapped pDNA remaining in the
supernatant after centrifugation (13,500 rpm, 30 min) was calcu-
lated. For this purpose, the supernatant was used with the
corresponding of blank formulation for the calibration curve. It was
spectrophotometrically analyzed at 260 nm for pDNA concentra-
tion by NanoDropTM 2000/2000c Spectrophotometers.
Furthermore, the physical stability of CNs-pDNA nanoparticles
in physiological environment was also determined by 1% agarose
gel electrophoresis in Tris-borate EDTA buffer (4.45 mM Tris-base,
1 mM sodium EDTA, 4.45 mM boric acid) at 120 V for 30 min. Each
formulation was loaded on the gel after it was incubated in DMEM
medium at 37 C for 24 h and 48 h.
2.4. Cell culture
Human cervical (HeLa; ATCC), breast (MDA-MB-231; ATCC)
(seeding density 3  103 cells/cm2) and peripheral blood (THP-1;
ECACC) (seeding density 2 105 cells/ml) cancer cells were
cultured in Dulbecco’s Modified Eagle’s medium (DMEM) (for
HeLa and MDA-MB-231) or Roswell Park Memorial Institute
medium (RPMI 1640) (for THP-1). They were supplemented with
10% fetal calf serum (FCS) and an antibiotic and antimycotic mixed
solution (100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.25 mg/
ml amphotericin B) at 37 C in a humidified atmosphere in the
presence of 5% CO2 until they reached confluence. Typically, cells
were passaged by trypsinization (adherent cells) or direct dilution
(suspension cells) to a seeding density.
2.5. In vitro transfection studies
Cells were seeded onto 96-well plate at a density of 3  103
(HeLa and MDA-MB-231) or 2  104 (THP-1) cells per well and
treated with CNs-pDNA at different concentrations and weight
ratios of 500:1, 300:1 and 100:1. After 24 h incubation, the medium
and complexes were removed, media was replaced with fresh
medium additionally containing neomycin sulphate (1 mg/ml) as
selection agent. The live cells were examined after 96 h with In Cell
Analyzer 2000 (GE Healthcare, UK) equipped with a high
performance CCD camera. The percentage of transfected cells
(%) were calculated by qualitative analysis of the acquired images.
Each transfection experiment was carried out as triplicate. Stable
cell lines (stable CNs-pDNA) were obtained by continuous long-
term culture in medium supplemented 1 mg/ml neomycin
sulphate.
2.6. Cell viability and cell cycle analysis
MTT assay was performed to evaluate the cell viability after 24 h
treatment with different formulation of CNs-pDNA (500:1, 300:1
and 100:1). Briefly; cells were seeded onto 96-well plates at a
density of 3  103 (HeLa and MDA-MB-231) or 2 104 (THP-1) cells
per well. After 24 h treatment, the formulations were discarded
and replaced with MTT-containing medium (500 mg/ml). After 4 h
incubation at 37 C, formazan crystals were dissolved in anhydrous
dimethyl sulfoxide (DMSO). Absorbance was read at 570 nm
(measurement wavelength) and at 630 nm (reference wavelength)
by Tecan Infinite1 M200 absorbance mode microplate reader.
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as 100%.
The behaviour of cells in a given cell cycle position was
quantitated by ImageJ 1.37 v software (http://rsb.info.nih.gov/ij/
index.html) with DAPI as staining marker of the cell nuclei, after
72 h treatment with CNs-pDNA.
2.7. Senescence-associated b-galactosidase activity (SA-b-gal)
Cells were seeded onto 6-well plates at the density 104 (HeLa or
MDA-MB-231) or 6  105 (THP-1) cells/well and after 72 h
treatment with CNs-pDNA, they were fixed by fixation solution
containing 2% formaldehyde, 0.2% glutaraldehyde for 5 min, room
temperature (RT). Then, cells were washed two times with PBS and
staining solution was added (5 mM potassium ferrocyanide, 5 mM
potassium ferricyanide, 150 mM NaCl, 2 mM MgCl2, 1 mg/ml 5-
bromo-4-chloro-3-inolyl-b-D-galactoside (X-gal), 40 mM citric
acid/sodium phosphate, pH 6.0). After overnight incubation in
37 C, cells were washed with PBS and photographed with an
Olympus BX71 light inverted microscope equipped with a DP72
CCD camera and a computer image analysis system Cell^b. SA-
b-gal-positive cells were scored per 100 total cells analyzed [%].
2.8. Oxidative stress
Cells were seeded at a density of 3  103 cells/cm2 (HeLa and
MDA-MB-231) or 2 105 cells/ml (THP-1) and treated with CNs-
pDNA for 72 h (Rossert et al., 2014). Then, cells were washed and
suspended in PBS containing 0.1% glucose, 0.5 mM EDTA and 5 mM
20,70-dichlorodihydrofluorescein diacetate (H2DCF-DA) (Sudheesh
Kumar et al., 2013). Fluorescence light was monitored in a Tecan
Infinite1 M200 absorbance mode microplate reader at 495 nm
(measurement wavelength) and at 525 nm (reference wavelength)
(Mytych et al., 2014, 2015b).
2.9. Western blotting
Whole cell protein extracts were prepared according to Mytych
et al. (Mytych et al., 2014). Proteins were detected using primary
antibodies anti-p21 (1:100) (Abcam), anti-DNMT2 (1:500) or anti-
b-actin (1:10000) (Thermo Scientific) and a secondary antibody
conjugated to Horseradish Peroxidase (HRP) (1:80000). The
protein bands visualization was conducted using the PierceTM
ECL Western Blotting Substrate (Life Technologies) and a G:BOX
imaging system.
2.10. Statistical analysis
Data were presented as mean  standard deviation from at least
three independent experiments. Statistical significance was
assessed by One-way ANOVA using GraphPad Prism 5, and with
the Dunnett’s multiple comparison tests.Table 1
Physical and chemical characteristics of different CNs-pDNA formulations.
Formulationa Size (nm) PDI 
500:1 220  7.2 0.581 
300:1 206  11.8 0.364 
100:1 164  13.4 0.341 
CNsb 91.7  0.6 0.214 
PDI: Polydispersity index.
a Synthesized using different CS:pDNA weight ratios of 500:1, 300:1 and 100:1 at a 
b Synthesized initial chitosan nanoparticles without plasmid DNA.3. Results and discussion
3.1. Formation and characterization of CNs-pDNA
In the present study, the preparation of the chitosan nano-
particles was based on ionic gelation interactions between the
positively charged polymer and negatively charged TPP. According
to our initial studies, the optimized nanoparticle formation was
achieved with 5 mg/ml chitosan concentration and 4:1 CS:TPP
mass ratio. The obtained CNPs were spherical or ellipsoidal shape
having the size of 91.7  0.6 nm and the PDI of 0.214 supported by
DLS measurements. The formation of CNs with pDNA was
formulated using different CNs amount with fixed pDNA concen-
tration (10 mg/ml) and the formulated compounds were charac-
terized by physically and chemically in details. As shown in Table 1,
the ratio of mixing solution of CS and pDNA affect the particle size,
clearly. The size of nanoparticle formation was CS amount-
dependent, size was increased with higher CS in the formulation
as reported by others (Gan et al., 2005; Omar Zaki et al., 2015). The
five times increased CS amount resulted in nearly 1.5 times bigger
size nanoparticle formation.
The PDI value of chitosan nanoparticles was 0.214 while that of
pDNA loaded chitosan nanoparticles was 0.581 for the formulation
of 500:1 (CS:pDNA), thus indicating an acceptable particle size
distribution (PDI < 0.6) (Table 1). A small reduction was observed
in zeta potential according to increasing amount of the pDNA
loading. As it was discussed previously, this could be explained by
the presence of some negatively charged pDNA on the surface of
the nanoparticles (Csaba et al., 2009). The methodology employed
here resulted in high encapsulation efficiency of pDNA crosslinked
chitosan nanoparticles. The increasing amount of chitosan showed
a high efficiency for the encapsulation of pDNA, reaching almost
99% for the formulation with the highest theoretical DNA loading
(Table 1).
The shape of the CNs-pDNA was determined by atomic force
microscope (AFM). All the formulated compounds with different
pDNA loading have displayed similar well defined spherical shape
particles and some unwanted aggregates (Fig. 1). The heteroge-
neous morphology having suffered aggregates obtained in this
study agrees with previously reported studies (Erbacher et al.,
1998a; Köping-Höggård et al., 2003). The measured size of CNs-
pDNA by AFM was almost same as obtained by DLS.
Gel electrophoresis studies were performed to assess the
association of pDNA within nanoparticles after incubated in DMEM
medium for 24 h and 48 h. As shown in Fig. 2, naked pDNA release
was not detected following incubation of CNs-pDNA nanoparticles
up to 48 h in the medium. These results indicated that pDNA was
very tightly associated to all nanoparticles formulation including
500:1, 300:1 and 100:1 ratios.
3.2. Cell type-dependent cytostatic effect of CNs and CNs-pDNA
In the first step of in vitro experiments we decided to choose
working concentration of CNs-pDNA for further studies. That wasz Potential (mV) Encapsulation efficiency (%)
+37.5  4.6 94.77  4.37
+33.8  1.8 97.42  2.03
+21.6  3.2 80.95  1.03
+31.8  1.4 –
constant pDNA concentration of 10 mg/ml.
Fig. 1. Typical topographic Height Sensor image of particles in suspension obtained by atomic force microscopy (AFM). Individual nanoparticles and their aggregates are
indicated by arrows. Nanoparticles were kept in DMEM medium for up to 2 days prior to AFM analysis.
Fig. 2. Binding efficiency between chitosan and pDNA at different CS:pDNA ratios by agarose gel retardation assay for 0 h, 24 h and 48 h. Each formulation was loaded on the
gel after it was incubated in DMEM medium at 37 C for 24 h and 48 h.
434 G. Bor et al. / International Journal of Pharmaceutics 513 (2016) 431–437possible by the evaluation of the impact of synthesized CNs-pDNA
used in the wide range of concentrations on the metabolic activity
of tested cells (Fig. 3A). Performed MTT assay revealed no
differences between controls and 24 h treated cells in the case
of HeLa and MDA-MB-231 cell lines. That is in agreement with
previous studies done in different cell line models, i.e. mouse
hematopoietic stem cells (Omar Zaki et al., 2015), human
respiratory epithelial cells (Grenha et al., 2007), human epithelial
liver cells (Yang et al., 2014), mouse epithelial-like cells (Ragelle
et al., 2014), mouse fibroblast colon cells (Hallaj-Nezhadi et al.,
2011), human mesenchymal stem cells (Corsi et al., 2003) and
human embryonic kidney cells (Corsi et al., 2003; Zhou et al., 2015).
On the other hand, only a few reports have shown an inhibition in
metabolic activity caused by CNs-pDNA treatment (Wimardhani
et al., 2014; Yao et al., 2013). Interestingly, in our study, THP-1
monocytic metabolic activity was reduced. Treatment with plain
CNs decreased their metabolic activity to the same level
irrespective of used concentration (to approximately 75–82%),
while CNs-pDNA-triggered reduction was ratio- and concentra-
tion-dependent. The observed variations may be the results of
methodological differences in CNs and CNs-pDNA preparation and
different amounts of particular components. As seen in Fig. 3, the
most pronounced effect was observed for the lowest concen-
trations of 500:1 CNs-pDNA (inhibition to 60%) and the highestconcentration of 300:1 and 100:1 CNs-pDNA (reduction to 54% and
51%, respectively).
As particulate carrier, CNs-pDNA containing multiple plasmids
were well characterized and their transfection efficiency seems to
be cell type-dependent (Corsi et al., 2003; Csaba et al., 2009;
Hallaj-Nezhadi et al., 2011; Mao et al., 2001). For example, Csaba
et al. (2009) showed that CNs-pDNA complexes were uptaken
through endocytosis by HEK293 cells and subsequent release into
the cytoplasm occurred within 14 h, while high gene expression
levels were observed two days after transfection (Csaba et al.,
2009). Similarly, Hallaj-Nezhadi et al. (2011) presented 2.8 times
improved transfection efficiency with the use of CNs-pDNA in
comparison to naked pDNA (Hallaj-Nezhadi et al., 2011). In our
study, we evaluated the efficiency of transfection with CNs-pDNA
complexes (Fig. 3B). It was observed that the percentage of
transfected cells after 96 h treatment with the formulation 500:1
(27% HeLa, 19% MDA-MB-231 and 29% THP-1) was higher than
300:1 (19% HeLa,12% MDA-MB-231 and 21% THP-1) and 100:1 (21%
HeLa, 12% MDA-MB-231 and 24% THP-1). These results indicate
that CS:pDNA has high importance for the efficacy of transfection.
This is relevant with previously reported data about dependence of
the surface charge ratio on the efficacy of polyplex-based gene
delivery (Erbacher et al.,1998b; Lavertu et al., 2006; Romoren et al.,
2003; Yue et al., 2011). Furthermore, independently from CS:pDNA
Fig. 3. (A) Cell type-dependent reduction in metabolic activity due to the 24 h treatment with different volumes (%) and ratios of CNs-pDNA. (B) Transfection efficiency (%) of
CNs-pDNA formulations at different ratio of 500:1, 300:1 and 100:1 after 96 h of transfection (C) Changes in the cell cycle profile due to the 72 h treatment with 1% 500:1 CNs-
pDNA. 1% 500:1 CNs-pDNA. Bars indicate SD, n = 3, ***p < 0.001, **p < 0.01, *p < 0.05.
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transfected cells were positive for fluorescent protein presence in
almost 100% for all examined cell lines (data not shown). As
reported previously (Hallaj-Nezhadi et al., 2011), short-term
transfection efficiency with CNs-pDNA was lower than using
Lipofectamine 2000.
The selection of working concentration for further studies was
based on the interest in the identifying transfection efficiency of
various formulations. Then, we wanted to define mechanism
leading to the reduction of the metabolic activity of THP-1 treated
with CNs-pDNA, thus we decided to check whether that process is
due to the proliferation inhibition or cell death (Fig. 3C). Therefore,
we determined cell cycle profile and found these disruptions
caused by 72 h treatment with CNs-pDNA. It was observed that the
% of THP-1 cells in the G0/G1 phase increased and in the S phase
decreased at the same time. Moreover, in all examined stable
transfected cells we observed G0/G1 cell cycle arrest. At the same
time, the apoptotic cell death did not take place (data not shown).
That process seems to be also cell type-dependent. For instance, in
HaCaT, but not Ca9-22 cells, caspase-independent apoptosis was
induced. However, exposure to CNs resulted in a significant
increase in the G1 phase population (from 33% to 51%) indicating
cell cycle arrest in Ca9-22 cells (Wimardhani et al., 2014).3.3. Independent of oxidative stress-induced premature senescence
Since oxidative stress was linked with NPs-mediated toxicity
(Manke et al., 2013; Mytych et al., 2015b) and affected cell cycle
progression (Boonstra and Post, 2004), we decided to check
whether that process also takes place in the applied conditions.
Changes in generation of total ROS were monitored for evaluation
of CNs-mediated oxidative stress induction in the tested cells and
their reduction was observed (Fig. 4A). Moreover, antioxidant
activity of CNs was coupled with their ability to suppress the
production of lipid peroxidation, restore activity of endogenous
antioxidant and increase total antioxidant capacity. Similar results
were shown in in vitro (Wen et al., 2013) and in vivo (El-Denshary
et al., 2015) models.
It is widely accepted that irreversible cell cycle arrest may lead
to stress-induced premature senescence (SIPS), characterised by
cytomorphological and metabolic changes (Correia-Melo and
Passos, 2015). Moreover, recent findings suggest the possibility
of induction of SIPS independently of ROS generation (Ziegler et al.,
2015). In the present study, we noted the increase of the% of the
cells positive for the presence of SA-b-gal, which widely serves as a
senescence marker (Fig. 4B). The most sensitive cell line was MDA-
MB-231 with the 3 times increased population of SA-b-gal positive
Fig. 4. (A) CNs-pDNA-mediated reduction in generation of total ROS. (B) CNs-pDNA-induced premature senescence. (C) Effect of 1% 500:1 CNs-pDNA on protein expression
profiles. Bars indicate SD, n = 3, ***p < 0.001, **p < 0.01, *p < 0.05; microscopic magnification of the objective lens 10.
436 G. Bor et al. / International Journal of Pharmaceutics 513 (2016) 431–437cells, while for HeLa and THP-1 the observed change was 1.6 and 2
times higher, respectively. Furthermore, the evaluation of the level
of p21 protein, another widely known marker of senescence
involves as well in cell cycle arrest, was also performed (Fig. 4C). An
up regulation was observed and the most pronounced effect was
noted for MDA-MB-231 cell line. It was already shown that NPs can
induce both, p21-dependent and p21-independent, premature
senescence (Mytych et al., 2014, 2015b). Interestingly, we here
report similar observation in the context of CNs-pDNA for the first
time. That process may be mediated by overexpression of TGF-beta
1 which further activates p15 and p21 and leads to cell cycle arrest,
resulting in cellular senescence (Gong et al., 2003; Senturk et al.,
2010). The possibility that SIPS was caused by overexpression of
the gene carried by CNs-pDNA and protein accumulation was
excluded due to the fact that expressed fluorescent protein was
characterized as non-toxic and biologically inert (Henderson and
Remington, 2006). Furthermore, among many mechanisms
engaged in senescence induction, also DNA and RNA methylation
seems to play an important role (Machwe et al., 2000; Oh et al.,
2015; So et al., 2011; Young and Smith, 2001). Besides that, DNA
methyltransferase II (DNMT2), enzyme with the enigmatic role inthe RNA methylation, was found to have protective role in the NPs-
induced stress (Mytych et al., 2014). Therefore, we decided to check
whether CNs-pDNA treatment affects the pool of DNMT2 in tested
cell lines and indeed, the level of DNMT2 was elevated in THP-1
cells (Fig. 3C). Perhaps, DNMT2 upregulation in that case may
result in RNA stabilization and confer stress resistance.
4. Conclusions
In summary, in the present study, nanoparticles based on
chitosan for delivery of pKindling-red-Mito vector were succes-
sively generated by ionic gelation method at different ratio of CS:
pDNA (500:1, 300:1, 100:1) with at least 80% encapsulation
efficiency and high stability. The transfection efficiency of particles
was dependent on cell type and formulation. Moreover using
different cell line models we showed that CNs-pDNA biocompati-
bility is limited and observed effects are cell-type dependent. HeLa
and MDA-MB-231 cell lines, which are derived from solid tumors
and exhibit adherent properties in in vitro culture, were more
resistant to applied treatment than derived from blood THP-1 cells.
This observation may be related to limited availability of CNs-
G. Bor et al. / International Journal of Pharmaceutics 513 (2016) 431–437 437pDNA to HeLa and MDA-MB-231 cell lines compared to THP-1 cells.
Taking into account of the observed effects, the fact that monocytes
are the first cells which are in contact with the CNs-pDNA after in
vivo administration. It is crucial to understand these interactions in
details before adopting proposed systems in biological and medical
applications.
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